ID Biomedical To Initiate Fluviral Trial For U.S. Approval By End Of January
ID Biomedical will begin enrolling subjects in a clinical trial evaluating its influenza vaccine Fluviral for U.S. approval before the end of January
ID Biomedical will begin enrolling subjects in a clinical trial evaluating its influenza vaccine Fluviral for U.S. approval before the end of January